Steven Foster - Nov 14, 2025 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role
CEO and President, Director
Signature
/s/ Steven Foster
Stock symbol
TNON
Transactions as of
Nov 14, 2025
Transactions value $
$0
Form type
4
Date filed
11/18/2025, 08:42 PM
Previous filing
Oct 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FOSTER STEVEN M CEO and President, Director 104 COOPER CT., LOS GATOS /s/ Steven Foster 2025-11-18 0001897435

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNON Common stock Purchase +19.5K +568.36% 22.9K Nov 14, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNON Common Stock Purchase Warrant Purchase +19.5K 19.5K Nov 14, 2025 Common Stock 19.5K $1.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.